The audience for this educational initiative is pediatric rheumatologists, pediatric neonatologists, pediatric nephrologists, and pediatric endocrinologists.


  • Implement strategies to diagnose FOP early and differentiate it from other bone lesions

  • Discuss the pathophysiology and key translational studies for FOP and their clinical context

  • Describe emerging therapies for FOP, their efficacy and safety, and their place in therapy


This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Medical Education Resources (MER) and CMEology.  MER is accredited by the ACCME to provide continuing medical education for physicians.



Medical Education Resources designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in this activity. 


It is the policy of Medical Education Resources (MER) to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Conflicts are resolved by MER to ensure that all scientific research referred to, reported, or used in a continuing education activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing its learners with high-quality activities that promote improvements or quality in health care and not the business interest of a commercial interest.


The content and views presented in this educational activity are those of the faculty and do not necessarily reflect those of Medical Education Resources, CMEology, and/or Clementia Pharmaceuticals Inc. The faculty have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Primary references and full prescribing information should be consulted before prescribing any medicine. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.



Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please e-mail Beth Goodwin prior to the live event at


There is no fee for this educational activity.